Lessee, Operating Lease, Liability, to be Paid, Year Four of Stoke Therapeutics, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Stoke Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • Stoke Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2025 was $473,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Stoke Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $473,000 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $473,000 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $532,000 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2021 $173,000 31 Dec 2021 10-K 10 Mar 2022 2021 FY
Q3 2021 $173,000 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $172,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.